Sedana Medical AB (FRA:7D2A) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7D2A Sedana Medical AB FRA:7D2A
69 GF Score
Price €0.86
GF Value €1.47
! 2 Warning Signs
View Full Analysis

What is Sedana Medical AB FFO per Share?

FFO per Share only applies to REITs.

FRA:7D2A
69GF Score
Sedana Medical AB FRA:7D2A
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sedana Medical AB (FRA:7D2A) Overvalued in 2026?

Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued. The current stock price of €0.86 is trading 41.7% below its estimated GF Value™ of €1.47.

Key valuation signals for FRA:7D2A:

  • FFO per Share:
  • GF Value™: €1.47 vs. price of €0.86 (41.7% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the FRA:7D2A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sedana Medical AB Business Description

Other Exchanges SEDANA:Sweden
Address Svardvagen 3A, Danderyd, SWE, SE-182 33
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score

Get the complete analysis for FRA:7D2A

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.86
Price
€1.47
GF Value